Who owns 74319F957 - BIORA THERAPEUTICS INC - COM - Put based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

BIORA THERAPEUTICS INC - COM - Put Institutional Ownership

Q: What is CUSIP 74319F957?

CUSIP 74319F957 is the security identifier used in SEC filing datasets for 74319F957 - BIORA THERAPEUTICS INC - COM - Put.

CUSIP: 74319F957

13F Institutional Holders and Ownership History from Q1 2021 to Q1 2023

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 74319F957?
CUSIP 74319F957 identifies 74319F957 - BIORA THERAPEUTICS INC - COM - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 74319F957:

Q1 2023 (0 holders) Q4 2022 (0 holders) Q3 2022 (0 holders) Q2 2022 (0 holders) Q1 2022 (1 holder) Q4 2021 (1 holder) Q3 2021 (0 holders) Q2 2021 (0 holders) Q1 2021 (0 holders)

Institutional Holders of BIORA THERAPEUTICS INC - COM - Put across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Price (Median)	Investors
2023 Q1				$0		0
2022 Q4				$24,148	$0.13	0
2022 Q3				$347,000	$0.48	0
2022 Q2	0	$0	-$73,000	$815,000	$0.70	0
2022 Q1	63,300	$73,000	+$56,278	$1,290,000	$1.16	1
2021 Q4	14,500	$30,000	+$30,000	$3,136,000	$2.09	1
2021 Q3				$865,000	$3.41	0
2021 Q2				$101,000	$3.56	0
2021 Q1				$26,000	$472.73	0